Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-γ-treated skin cells in a co-culture system

Wound Repair and Regeneration

Volumn 11, Issue 5, 2003, Pages 337-345

  Sarkhosh, Kourosh ^a   Tredget, Edward E ^a   Li, Yunyuan ^a   Kilani, Ruhangiz T ^a   Uludag, Hasan ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MESSENGER RNA; N METHYLTRYPTOPHAN;

ARTICLE; BURN; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FETUS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN ALLOGRAFT; SKIN FIBROBLAST; WOUND;

CELL DIVISION; COCULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KERATINOCYTES; LEUKOCYTES, MONONUCLEAR; TRYPTOPHAN OXYGENASE;

EID: 0141789584     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2003.11505.x     Document Type: Article

References (29)

1. Linares AZ, Linares HA. Bum prevention: the need for a comprehensive approach. Burns 1990;16:281-5.
2. Boyce ST, Warden GD, Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Am J Surg 2002;183:445-56.
3. Ryan CA, Shankowsky HA, Tredget EE. Profile of the paediatric bum patient in a Canadian burn centre. Burns 1992;18:267-72.
4. Cairns BA, deSertas S, Peterson HD, Meyer AA. Skin replacements. The biotechnological quest for optimal wound closure. Arch Surg 1993;128:1246-52.
5. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-43.
6. Gallico GG, 3rd O'Connor NE, Compton CC, Kehinde O, Green H. Permanent coverage of large bum wounds with autologous cultured human epithelium. New Engl J Med 1984;311:448-51.
7. Taylor MW, Feng GS. Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991;5:2516-22.
8. Gresser I. Antitumor effects of interferon. Acta Oncologica 1989;28:347-53.
9. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281 (5380):1191-3.
10. Kamimura S, Eguchi K, Yonezawa M, Sekiba K. Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama 1991;45:135-9.
11. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T-cell driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64-8.
12. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 2002;196:459-68.
13. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbins PD, Trucco M. Indoleamine 2, 3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002;51:356-65.
14. Takikawa O, Kuriowa T, Yamazaki F, Kido R. Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 1988;263:2041-8.
15. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-7. Annu Rev Immunol 1997;15:749-95.
16. Dai W, Pan H, Kwok O, Dubey JP. Human indoleamine 2,3-dioxygenase inhibits toxoplasma gondii growth in fibroblast cells. J Interferon Res 1994;14:313-7.
17. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, Hong Z, Lau JY, Tam RC. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 2002;76:1148-54.
18. Daubener W, MacKenzie CR. IFN-gamma activated indoleamine 2, 3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol 1999;467:517-24.
19. Burke F, Knowles RG, East N, Balkwill FR. The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-gamma in vivo. Intl J Cancer 1995;60:115-22.
20. 125-human interferon-gamma to high affinity receptors on human fibroblasts. J Biol Chem 1982;257:11301-4.
21. Koizumi H, Tanaka H, Fukaya T, Yasui C, Ohkawara A. Translocation of protein kinase C from cytosol to membrane fractions in human epidermal keratinocytes by recombinant human interferon-gamma. J Dermatol Sci 1990;1:297-302.
22. Sadir R, Lortat-Jacob H, Morel G. Internalization and nuclear translocation of IFN-γ and IFN-γ R: an ultrastructural approach. Cytokine 2000;12:711-4.
23. Feng GS, Taylor MW. Interferon-gamma resistant mutants are defective in the induction of indoleamine 2,3-dioxygenase. Proc Natl Acad Sci U S A 1989;86:7144-8.
24. Cauza K, Grassauer A, Hinterhuber G, Horvat R, Rapperberger K, Wolff K, Foedinger D. FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. J Invest Dermotol 2002;119:1074-9.
25. Schwarz G, Boehncke WH, Braun M, Schroter CJ, Burster T, Flad T, Dressel D, Weber E, Schmid H, Kalbacher H, Cathepsin S. activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma. J Invest Dermotol 2002;199:44-9.
26. Ghahary A, Shen Q, Rogers JA, Wang R, Fathi-Afshar A, Scott PG, Tredget EE. Liposome-associated interferon-alpha-2b functions as an anti-fibrogenic factor for human dermal fibroblasts. J Invest Dermatol 1997;109:55-60.
27. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 1979;18:5294-9.
28. Balasubramani M, Kumar TR, Babu M. Skin substitutes: a review. Burns 2001;27:534-44.
29. Holmes EW. Expression and regulation of interferon-gamma-induced tryptophan catabolism in cultured skin fibroblasts. J Interferon Cyt Res 1998;18:509-20.